BFA
MYOV

BlackRock Fund Advisors’s Myovant Sciences Ltd. MYOV Stock Holding History

BlackRock Fund Advisors’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$3.87M Buy
+311,323
New +$3.61M ﹤0.01% 3012

Other funds holding MYOV

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

BlackRock Fund Advisors's MYOV Position: Q4 2016 in Review

BlackRock Fund Advisors opened a new position in Myovant Sciences Ltd. (MYOV) in Q4 2016: 311,323 shares worth $3.87M. The stake represents ﹤0.01% of the portfolio and ranks #3012 among its holdings.

52 funds tracked by Wall St. Rank hold MYOV as of Q4 2016.

  • BlackRock Fund Advisors held 311,323 shares of Myovant Sciences Ltd. worth $3.87M as of Q4 2016.
  • Myovant Sciences Ltd. was a new BlackRock Fund Advisors position in Q4 2016.
  • Myovant Sciences Ltd. made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3012 holding.
  • 52 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.